Skip to main content

Table 2 Outcomes measures at the baseline, the end of the MBSR program (3 months) (V1), and the final follow-up (6 months) (V2)

From: Evaluation of mindfulness based stress reduction in symptomatic knee or hip osteoarthritis patients: a pilot randomized controlled trial

 

MBSR group

Usual care group

P value

Primary Outcome (mean (SD))

WOMAC pain

 Baseline

55.6 (16.7) (n = 20)

47.9 (14.8) (n = 20)

0.15

 V1

47.2 (17.6) (n = 18)

36.7 (25.7) (n = 12)

0.19

 V2

38.0 (19.8) (n = 20)

39.7 (20.3) (n = 15)

0.80

Secondary Outcomes (mean (SD))

WOMAC function

 Baseline

49.0 (19.2) (n = 20)

45.5 (14.4) (n = 20)

0.54

 V1

43.3 (17.0) (n = 13)

36.4 (24.3) (n = 13)

0.41

 V2

38.5 (19.6) (n = 18)

39.7 (22.0) (n = 14)

0.86

WOMAC stiffness

 Baseline

59.4 (17.6) (n = 20)

52.2 (22.1) (n = 20)

0.28

 V1

55.3 (23.7) (n = 19)

48.3 (19.4) (n = 15)

0.36

 V2

40.6 (16.7) (n = 20)

48.4 (25.8) (n = 16)

0.27

WOMAC total

 Baseline

55.1 (13.6) (n = 20)

48.6 (14.8) (n = 20)

0.20

 V1

46.4 (16.6) (n = 12)

38.4 (22.5) (n = 11)

0.34

 V2

40.7 (16.5) (n = 18)

43.7 (22.4) (n = 14)

0.67

VAS pain

 Baseline

64.0 (12.2) (n = 20)

60.0 (12.7) (n = 20)

0.30

 V1

41.4 (25.3) (n = 20)

44.8 (26.5) (n = 16)

0.70

 V2

34.4 (27.2) (n = 20)

48.7 (26.9) (n = 16)

0.12

SF36 physical score

 Baseline

34.8 (8.1) (n = 20)

36.1 (8.2) (n = 18)

0.62

 V1

36.6 (7.9) (n = 20)

39.5 (9.5) (n = 15)

0.33

 V2

38.6 (10.5) (n = 20)

40.1 (11.8) (n = 15)

0.68

SF36 mental score

 Baseline

48.1 (9.6) (n = 20)

42.4 (12.0) (n = 20)

0.11

 V1

50.7 (7.9) (n = 20)

41.8 (11.4) (n = 15)

0.01*

 V2

50.0 (8.6) (n = 20)

41.3 (14.3) (n = 15)

0.11

HAD anxiety

 Baseline

7.3 (4.0) (n = 20)

8.4 (4.3) (n = 20)

0.40

 V1

5.2 (3.4) (n = 20)

8.4 (4.3) (n = 15)

0.08

 V2

6.2 (4.4) (n = 20)

7.5 (4.7) (n = 16)

0.08

HAD depression

 Baseline

4.1 (3.3) (n = 20)

5.3 (3.6) (n = 20)

0.28

 V1

3.4 (2.2) (n = 20)

4.8 (3.5) (n = 15)

0.14

 V2

3.5 (2.9) (n = 20)

5.1 (3.9) (n = 16)

0.21

FFMQ observation factor

 Baseline

29.3 (5.5) (n = 19)

26.9 (5.9) (n = 20)

0.20

 V1

31.9 (4.2) (n = 20)

26.9 (5.9) (n = 16)

0.03*

 V2

32.1 (4.5) (n = 20)

26.6 (5.8) (n = 16)

0.01*

FFMQ description experience factor

 Baseline

29.0 (5.4) (n = 19)

28.3 (6.8) (n = 19)

0.74

 V1

30.1 (4.7) (n = 20)

29.7 (7.4) (n = 15)

0.87

V2

31.1 (4.7) (n = 20)

30.0 (8.2) (n = 16)

0.83

FFMQ mindfulness factor

 Baseline

28.6 (6.3) (n = 19)

27.8 (5.7) (n = 19)

0.70

 V1

29.0 (6.5) (n = 19)

28.1 (6.9) (n = 16)

0.71

 V2

30.1 (6.6) (n = 20)

29.4 (6.8) (n = 15)

0.76

FFMQ private event factor

 Baseline

18.8 (5.0) (n = 19)

21.2 (3.9) (n = 20)

0.11

 V1

23.8 (5.7) (n = 19)

19.6 (4.1) (n = 15)

0.02*

 V2

23.1 (5.2) (n = 20)

21.2 (4.3) (n = 16)

0.25

FFMQ no judgment factor

 Baseline

28.0 (5.8) (n = 20)

26.3 (7.4) (n = 20)

0.41

 V1

28.2 (6.2) (n = 19)

28.5 (6.6) (n = 15)

0.86

 V2

30.7 (6.4) (n = 20)

27.1 (7.5) (n = 16)

0.13

FFMQ total mindfulness

 Baseline

133.2 (17.0) (n = 18)

131.1 (21.8) (n = 18)

0.74

 V1

145.0 (20.0) (n = 18)

131.5 (25.0) (n = 13)

0.10

 V2

147.0 (17.3) (n = 20)

133.7 (26.4) (n = 15)

0.08

  1. VAS visual analogic scale, WOMAC Western Ontario and McMaster Universities Osteoarthritis Index, SF-36 36-Item Short-Form Health Survey, FFMQ Five Facets Mindfulness Questionnaire, HAD hospital anxiety and depression
  2. *Significant difference between groups